Method of generating an index score for mbl deficiency to predict cardiodiabetes risk
AssigneeHealth Diagnostic Laboratory, Inc.
InventorsRebecca E. Caffrey, James Pottala, Stephen Varvel
Life of this patent
Estimating the term…
Loading patent…
AssigneeHealth Diagnostic Laboratory, Inc.
InventorsRebecca E. Caffrey, James Pottala, Stephen Varvel
Estimating the term…
This application relates to methods of predicting susceptibility or likelihood of a clinically-relevant mannose-binding lectin (MBL)-deficient subject to develop a cardiovascular disease and/or cardiodiabetes. The methods include measuring MBL mass or concentration and, optionally, measuring MBL activity, at least one other biomarker and/or genotyping of MBL gene and its promoters; combining the information obtained into a calculated MBL-inclusive index score that involves mathematical transformation; and assigning a risk of cardiadiabetic status and clinical endpoints based on the determination and comparison of the MBL inclusive index to reference values from a population.
A method for predicting susceptibility or likelihood of a subject having a clinically-relevant mannose-binding lectin (MBL) deficiency to develop cardiodiabetes, comprising:
A method for predicting susceptibility or likelihood of a subject having a clinically-relevant mannose-binding lectin (MBL) deficiency to develop cardiodiabetes, comprising:
A method for predicting susceptibility or likelihood of a subject having a clinically-relevant mannose-binding lectin (MBL) deficiency to develop cardiodiabetes, comprising:
Dependencies are inferred from the claim text.